Arcutis Biotherapeutics
Xiangyi Meng, Ph.D., is an accomplished biostatistician with extensive experience in the pharmaceutical industry. Currently serving as Executive Director and Head of Biostatistics at Arcutis Biotherapeutics, Inc., since April 2023, Meng previously held the position of Director of Biostatistics and Head of Analytics at Novartis Pharmaceuticals from March 2006 to February 2023. Prior experience includes leadership roles at Clinsys Clinical Research and Scirex, focusing on statistical activities across various therapeutic areas, including oncology and neuroscience, and contributing to New Drug Applications (NDA) and Biologics License Applications (BLA). Academic qualifications include a Ph.D. in Biostatistics from UCLA and a Postdoctoral Fellowship in the same field from UCLA’s Fielding School of Public Health.
This person is not in any teams
This person is not in any offices
Arcutis Biotherapeutics
3 followers
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.